Chronic Remote Ischemic Conditioning on Mild Hypertension in the Absence of Antihypertensive Medication: a Multicenter, Randomized, Double-Blind, Proof-of-Concept Clinical Trial
机构:[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.神经科系统神经内科首都医科大学宣武医院[2]Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China科技平台低氧适应转化医学北京市重点实验室首都医科大学宣武医院[3]Peking University Care Health Management Center, Beijing, China[4]Health Management Center, The 306 Hospital of People's Liberation Army, Beijing, China[5]Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China内科系统急诊科首都医科大学宣武医院[6]Health Management Center, Xuanwu Hospital, Capital Medical University, Beijing, China首都医科大学宣武医院[7]Center for Evidence-Based Medicine, Xuanwu Hospital of Capital Medical University, Beijing, China首都医科大学宣武医院[8]Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School[9]National Heart Research Institute Singapore, National Heart Centre[10]Yong Loo Lin School of Medicine, National University Singapore[11]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China神经科系统神经外科首都医科大学宣武医院
Exploratory studies have shown that remote ischemic conditioning (RIC) has the potential to lower blood pressure (BP). We investigated whether chronic RIC reduces BP for hypertension.This is a multicenter, randomized, double-blind, parallel-controlled trial. Patients with an office BP of 130/80 to 160/100 mm Hg and a 24-hour average BP ≥125/75 mm Hg not on antihypertensive medications were recruited. After a 1-week compliance screening phase, they were randomly assigned in a 1:1 ratio to receive RIC or sham RIC twice daily for 4 weeks. The primary efficacy outcome was the change in 24-hour average systolic BP from baseline to 4 weeks. Safety events were assessed over the study period.Ninety-five participants were randomly allocated to the RIC (n=49) and sham RIC (n=46) groups. In the intention-to-treat analysis, the reduction in 24-hour average systolic BP was greater in the RIC group than the sham RIC group (-4.6±9.5 versus -0.9±6.8 mm Hg; baseline-adjusted between-group mean difference: -3.6 mm Hg [95% CI, -6.9 to -0.3 mm Hg]; adjusted P=0.035). The per-protocol analysis showed that 24-hour average systolic BP reduced -5.9±8.6 mm Hg in the RIC group and -0.7±6.7 mm Hg in the sham RIC group (baseline-adjusted between-group mean difference: -5.2 mm Hg [95% CI, -8.5 to -1.9 mm Hg]; adjusted P=0.002). No major adverse events were reported in both groups.RIC is safe in patients with mild hypertension and may lower BP in the absence of antihypertensive medications. However, the effects of RIC on clinical outcomes in these patients require further investigation.URL: https://www.gov; Unique identifier: NCT04915313.
基金:
This study was supported by Beijing Natural Science Foundation (JQ22020),
Beijing Nova Program (No. Z201100006820143), National Natural Science
Foundation of China (No. 82001257, 81801313, and 81971114) and General
Project of Science and Technology of Beijing Municipal Education Commission
(No. KM202110025018).
第一作者机构:[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构:[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.[2]Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China[6]Health Management Center, Xuanwu Hospital, Capital Medical University, Beijing, China[11]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China[*1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun St, Xicheng District, Beijing 100053, China[*2]Health Management Center, Xuanwu Hospital, Capital Medical University, No. 45, Changchun St, Xicheng District, Beijing 100053, China[*3]Department of Neurology, Xuanwu Hospital, Capital Medical University, No. 45, Changchun St, Xicheng District, Beijing 100053, China
推荐引用方式(GB/T 7714):
Guo Wenting,Zhao Wenbo,Li Dong,et al.Chronic Remote Ischemic Conditioning on Mild Hypertension in the Absence of Antihypertensive Medication: a Multicenter, Randomized, Double-Blind, Proof-of-Concept Clinical Trial[J].HYPERTENSION.2023,80(6):1274-1282.doi:10.1161/HYPERTENSIONAHA.122.20934.
APA:
Guo Wenting,Zhao Wenbo,Li Dong,Jia Haiying,Ren Changhong...&Ji Xunming.(2023).Chronic Remote Ischemic Conditioning on Mild Hypertension in the Absence of Antihypertensive Medication: a Multicenter, Randomized, Double-Blind, Proof-of-Concept Clinical Trial.HYPERTENSION,80,(6)
MLA:
Guo Wenting,et al."Chronic Remote Ischemic Conditioning on Mild Hypertension in the Absence of Antihypertensive Medication: a Multicenter, Randomized, Double-Blind, Proof-of-Concept Clinical Trial".HYPERTENSION 80..6(2023):1274-1282